APOLLO ENDOSURGERY INC's ticker is APEN and the CUSIP is 03767D108. A total of 30 filers reported holding APOLLO ENDOSURGERY INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,022,987 | -82.7% | 103,124 | -82.6% | 0.00% | -83.3% |
Q4 2022 | $5,920,233 | +12.8% | 593,805 | -37.7% | 0.01% | 0.0% |
Q3 2022 | $5,248,000 | +838.8% | 952,732 | +927.1% | 0.01% | +1100.0% |
Q1 2022 | $559,000 | -46.8% | 92,760 | -25.6% | 0.00% | -50.0% |
Q4 2021 | $1,050,000 | +395.3% | 124,741 | +67.7% | 0.00% | – |
Q4 2019 | $212,000 | -75.7% | 74,401 | -71.6% | 0.00% | -100.0% |
Q3 2019 | $871,000 | -21.5% | 261,894 | -23.1% | 0.00% | 0.0% |
Q2 2019 | $1,109,000 | -15.9% | 340,484 | -3.6% | 0.00% | 0.0% |
Q1 2019 | $1,319,000 | +5.0% | 353,130 | -3.3% | 0.00% | -33.3% |
Q4 2018 | $1,256,000 | -57.3% | 365,034 | -11.0% | 0.00% | -50.0% |
Q3 2018 | $2,942,000 | +1.6% | 410,234 | -1.2% | 0.01% | 0.0% |
Q2 2018 | $2,897,000 | +42.2% | 415,402 | +25.4% | 0.01% | +100.0% |
Q1 2018 | $2,037,000 | +18.1% | 331,163 | +7.5% | 0.00% | 0.0% |
Q4 2017 | $1,725,000 | +33.9% | 308,035 | +11.9% | 0.00% | +50.0% |
Q3 2017 | $1,288,000 | – | 275,171 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parian Global Management LP | 820,388 | $7,433,000 | 5.19% |
Gagnon Advisors, LLC | 1,329,354 | $12,044,000 | 4.78% |
Stonepine Capital Management, LLC | 912,125 | $8,264,000 | 3.76% |
CPMG Inc | 3,194,871 | $28,946,000 | 3.19% |
GAGNON SECURITIES LLC | 1,540,928 | $13,961,000 | 2.07% |
Parkman Healthcare Partners LLC | 831,214 | $7,531,000 | 1.90% |
Archon Capital Management LLC | 756,154 | $6,851,000 | 0.97% |
Manatuck Hill Partners, LLC | 238,500 | $2,161,000 | 0.76% |
Nantahala Capital Management | 2,514,328 | $22,780,000 | 0.72% |
EAM Investors, LLC | 209,706 | $1,900,000 | 0.32% |